News NEURONES

Stocks

NRO

FR0004050250

IT Services & Consulting

Market Closed - Euronext Paris 12:55:00 2026-10-30 EDT			5-day change	1st Jan Change
38.05 ^EUR	+0.13%		+4.25%	-11.61%

09-20	Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index	CI
09-09	NEURONES Reaffirms Earnings Guidance for the Full Year of 2026	CI

All News

Mentions Relevance

09-20	Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index	CI
09-09	NEURONES Reaffirms Earnings Guidance for the Full Year of 2026	CI
09-09	Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	Neurones posts higher first-half results
09-09	NEURONES: 6.9% net profit in 1st half 2026	GL
08-05	Neurones posts strong growth
08-05	NEURONES: Organic growth up 8% in 2nd quarter 2026	GL
08-05	NEURONES Raises Earnings Guidance for the Full Year 2026	CI
08-05	Neurones S.A. Reports Revenue Results for the Second Quarter and First Half of 2026	CI
06-30	NEURONES: Declaration of transactions on treasury shares (June 22 to 26, 2026)	GL
06-22	NEURONES: Declaration of transactions on treasury shares (June 15 to 19, 2026)	GL
06-15	NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)	GL
06-08	NEURONES: Declaration of transactions on treasury shares (June 1 to 5, 2026	GL
06-04	NEURONES: Description of the share buyback program	GL
06-03	Neurones S.A.'s Equity Buyback announced on October 21, 2025, has expired.	CI
06-01	NEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)	GL
05-26	NEURONES: Declaration of transactions on treasury shares (May 18 to 22, 2026)	GL
05-18	NEURONES: Declaration of transactions on treasury shares (May 11 to 15, 2026)	GL
05-11	NEURONES: Declaration of transactions on treasury shares (May 4 to 8, 2026)	GL
05-06	Neurones reports solid organic growth in Q1
05-06	Neurones sees 2026 revenues around EUR 900 million	RE
05-06	NEURONES : 5.6 % increase in organic growth in the first quarter of 2026	PU
05-06	NEURONES: + 5.6% organic growth in Q1 2026	GL
05-06	Neurones S.A. Provides Earnings Guidance for the Full Financial Year 2026	CI
05-06	Neurones S.A. Announces Revenue Results for the First Quarter of 2026	CI